More about

Atopic Dermatitis

News
February 15, 2024
1 min read
Save

Dermavant submits new drug application for tapinarof cream in atopic dermatitis

Dermavant submits new drug application for tapinarof cream in atopic dermatitis

Dermavant Sciences has submitted a supplemental new drug application to the FDA for its Vtama cream 1% for the topical treatment of atopic dermatitis in patients aged 2 years and older, according to a company press release.

News
February 14, 2024
2 min read
Save

Vegetarian diets during pregnancy linked with less atopic dermatitis in children

Vegetarian diets during pregnancy linked with less atopic dermatitis in children

Vegetarian diets during pregnancy were associated with reduced risks for atopic dermatitis among children, according to a study published in Pediatric Allergy and Immunology.

News
February 14, 2024
1 min read
Save

FDA, EMA accept nemolizumab applications for prurigo nodularis, atopic dermatitis

FDA, EMA accept nemolizumab applications for prurigo nodularis, atopic dermatitis

The FDA and the European Medicines Agency have accepted applications for nemolizumab for the treatment of prurigo nodularis and severe atopic dermatitis in adolescents and adults, Galderma announced in a press release.

News
February 14, 2024
2 min read
Save

Vegetarian diets during pregnancy linked with less atopic dermatitis in children

Vegetarian diets during pregnancy linked with less atopic dermatitis in children

Vegetarian diets during pregnancy were associated with reduced risks for atopic dermatitis among children, according to a study published in Pediatric Allergy and Immunology.

News
February 13, 2024
1 min read
Save

Atopic dermatitis patients resistant to systemic treatment respond to tralokinumab

Atopic dermatitis patients resistant to systemic treatment respond to tralokinumab

MIAMI BEACH, Fla. — Patients with atopic dermatitis resistant to systemic therapy, including dupilumab, may benefit from tralokinumab treatment, according to a poster presentation here.

News
February 11, 2024
2 min read
Save

‘With great power comes great responsibility’: Boxed warnings in pediatric dermatology

‘With great power comes great responsibility’: Boxed warnings in pediatric dermatology

MIAMI BEACH, Fla. — Pediatric dermatologists should be open with patients and families when discussing boxed warnings while emphasizing that the benefits outweigh the risks, according to a speaker here.

News
February 10, 2024
1 min watch
Save

VIDEO: Upadacitinib could produce ‘rapid’ improvement in atopic dermatitis

VIDEO: Upadacitinib could produce ‘rapid’ improvement in atopic dermatitis

In this video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase inhibitor upadacitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.

News
February 10, 2024
1 min watch
Save

VIDEO: ‘No new safety events’ for abrocitinib in atopic dermatitis

VIDEO: ‘No new safety events’ for abrocitinib in atopic dermatitis

In this Healio exclusive video, Raj Chovatiya, MD, PhD, discussed research into the Janus kinase 1 inhibitor abrocitinib from the Maui Derm 2024 meeting, examining data into its use in treating atopic dermatitis.

News
February 09, 2024
1 min read
Save

Top in allergy/asthma: Oral immunotherapy has limitations; climate change worsens eczema

Top in allergy/asthma: Oral immunotherapy has limitations; climate change worsens eczema

Adults with food allergies experienced limited success with oral immunotherapy, according to results of a small cohort study.

News
February 09, 2024
2 min read
Save

JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases

JAK inhibitors have ‘untapped potential’ in treatment of inflammatory skin diseases

MIAMI BEACH, Fla. — Janus kinase inhibitors have a unique mechanism of action, giving them the potential to push the boundaries of efficacy in the treatment of inflammatory skin diseases, according to a speaker at South Beach Symposium.

View more